Article Test Cache 6 Apr 08, 2020 Save for later Filed under 23andMe Breast Cancer Breaking News Bipolar Disorder Risk Loci, Pathways Uncovered in Multi-Ancestry GWAS Leica Biosystems, Molecular Instruments Reach Deal on Immunohistochemistry Products Roche Gets 510(k) Clearance, CLIA Waiver for Liat Triplex Point-of-Care STI Test Abbott Q4 Diagnostics Revenues up 4 Percent, Excluding COVID-19 Tests MRC Holland Gains IVDR Certification for Spinal Muscular Atrophy Newborn Screening Test What's Popular? Study Failure Spotlights Challenges for ctDNA Strategies in Breast Cancer Drug Trials Premium African, Asian Ancestry Patients Less Likely to Be Eligible for New Precision Oncology Drugs Premium New Products Posted to GenomeWeb: New England Biolabs, BioSkryb, 23andMe, Parse Biosciences, NashBio HER2 Biomarker Evolving as Enhertu Shows Activity in Breast Cancers With Ultralow Expression Premium BRCA2 Variants Classified in Saturation Genome Editing Studies
